Hyman Charles D Merck & Co., Inc. Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hyman Charles D holds 189,656 shares of MRK stock, worth $18.3 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

189,656

Previous 187,391 1.21%

Holding current value

$18.3 Million

Previous $24.7 Million 5.04%

% of portfolio

1.31%

Previous 1.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$123.8 - $132.96 $280,407 - $301,154	2,265 Added 1.21%	189,656 $23.5 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $148,910 - $173,514	1,315 Added 0.71%	187,391 $24.7 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $319,674 - $347,882	3,191 Added 1.74%	186,076 $20.3 Million
Q3 2023 Nov 01, 2023	BUY	$102.95 - $114.33 $43,239 - $48,018	420 Added 0.23%	182,885 $18.8 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $334,518 - $364,610	3,080 Added 1.72%	182,465 $21.1 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $522,626 - $583,144	5,077 Added 2.91%	179,385 $19.1 Million
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $157,129 - $201,461	1,797 Added 1.04%	174,308 $19.3 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $1.19 Million - $1.34 Million	14,125 Added 8.92%	172,511 $14.9 Million
Q2 2022 Aug 02, 2022	BUY	$83.49 - $94.64 $163,890 - $185,778	1,963 Added 1.25%	158,386 $14.4 Million
Q1 2022 May 09, 2022	SELL	$73.51 - $82.4 $38,592 - $43,260	-525 Reduced 0.33%	156,423 $12.8 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $156,919 - $196,562	2,171 Added 1.4%	156,948 $12 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $855,357 - $940,678	11,933 Added 8.35%	154,777 $11.6 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $179,571 - $198,624	2,554 Added 1.82%	142,844 $11.1 Million
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $1.22 Million - $1.44 Million	17,717 Added 14.45%	140,290 $10.8 Million
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $125,812 - $139,626	1,753 Added 1.45%	122,573 $10 Million
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $1.31 Million - $1.48 Million	17,888 Added 17.38%	120,820 $10 Million
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $4.28 Million - $4.87 Million	60,807 Added 144.35%	102,932 $7.96 Million
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $562,636 - $779,841	8,880 Added 26.71%	42,125 $3.24 Million
Q4 2019 Feb 03, 2020	BUY	$77.58 - $87.54 $152,755 - $172,366	1,969 Added 6.3%	33,245 $3.02 Million
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $152 - $165	2 Added 0.01%	31,276 $2.63 Million
Q2 2019 Jul 24, 2019	BUY	$69.84 - $81.59 $8,939 - $10,443	128 Added 0.41%	31,274 $2.62 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $733,929 - $837,089	10,548 Added 51.21%	31,146 $2.59 Million
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $16,179 - $18,776	-248 Reduced 1.19%	20,598 $1.57 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $64,324 - $75,641	-1,115 Reduced 5.08%	20,846 $1.48 Million
Q2 2018 Aug 06, 2018	BUY	$50.83 - $59.72 $6,150 - $7,226	121 Added 0.55%	21,961 $1.33 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $42,449 - $49,338	833 Added 3.97%	21,840 $1.19 Million
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $24,158 - $28,847	-468 Reduced 2.18%	21,007 $1.18 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $129,250 - $139,075	2,203 Added 11.43%	21,475 $1.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,272	19,272 $1.24 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account